Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
Molecular Horizon, Bettona, Perugia, Italy.
Electrophoresis. 2024 Jun;45(11-12):1041-1053. doi: 10.1002/elps.202300278. Epub 2024 Mar 13.
In this paper, the development and application of a multiple heart-cutting achiral-chiral LC-LC method (mLC-LC) for the analysis of dansylated (Dns) branched-chain amino acids in commercial tablets are described. In the first dimension, a Waters Xbridge RP C18 achiral column was used under gradient conditions with buffered aqueous solution and acetonitrile. The elution order Dns-valine (Dns-Val) < Dns-isoleucine (Dns-Ile) < Dns-leucine (Dns-Leu) turned out with full resolution between adjacent peaks: 7.25 and 1.50 for the Val/Ile and the Ile/Leu pairs, respectively. A "research" validation study was performed, revealing high accuracy (Recovery%) and precision (RSD%) using two external set solutions, respectively, in the range 93.7%-104.1% and 0.4%-3.2%. The C18 column was connected via a two-position six-port switching valve to the quinidine-based Chiralpak quinidine-anion-exchange chiral column. A water/acetonitrile, 30/70 (v/v) with 50 mM ammonium acetate (apparent pH of 5.5) eluent allowed getting the three enantiomers' pairs resolved: R equal to 4.3 for Dns-Val and Dns-Ile, and 1.7 for Dns-Leu. The application of the mLC-LC method confirmed that the content of Val, Ile, and Leu in the tablets was compliant with that labeled by the producer. Only l-enantiomers were found in the food supplement, as confirmed by LC-MS/MS analysis.
本文描述了一种用于分析商业片剂中衍生化(Dns)支链氨基酸的多次切割手性-非手性 LC-LC 方法(mLCLC)的开发和应用。在第一维中,采用 Waters Xbridge RP C18 非手性柱,在缓冲水溶液和乙腈的梯度条件下进行洗脱。洗脱顺序为 Dns-缬氨酸(Dns-Val)<Dns-异亮氨酸(Dns-Ile)<Dns-亮氨酸(Dns-Leu),相邻峰之间完全分离:Val/Ile 对和 Ile/Leu 对的峰间距分别为 7.25 和 1.50。进行了一项“研究”验证研究,使用两种外部设定溶液分别在 93.7%-104.1%和 0.4%-3.2%的范围内显示出高准确度(Recovery%)和精密度(RSD%)。C18 柱通过双位置六通切换阀连接到基于奎尼丁的 Chiralpak 奎尼丁阴离子交换手性柱。水/乙腈,30/70(v/v),含 50 mM 乙酸铵(表观 pH 值为 5.5)洗脱液可实现三对对映体的分离:Dns-Val 和 Dns-Ile 的 R 值等于 4.3,Dns-Leu 的 R 值等于 1.7。mLCLC 方法的应用证实,片剂中 Val、Ile 和 Leu 的含量符合生产商的标注。通过 LC-MS/MS 分析证实,该膳食补充剂中仅含有 l-对映异构体。